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Exercise has been shown to be beneficial in alleviating several treatment related side-
effects in breast cancer survivors (BCS). However, few community-based exercise programs do 
exist to help BCS rehabilitate from cancer treatment related side-effects. The purpose of this 
study was to evaluate the effects of a community-based exercise program on fitness, physical 
function, and quality of life (QoL) outcomes. 
 Thirty-two BCS exercised for 16 weeks at the UNC Get Real and Heel (GRH) cancer 
program. VO2peak and 6MWT (20.9+5.2, 22.2+5.4, p = 0.04 and 536+72, 570+76, p<.001 
respectively), improved significantly from pre to post intervention. When the cohort was split 
into the highest and lowest adherence quartiles, significant improvement in QoL was observed 
for the high adherence group from pre to post intervention (76.2+12.8, 84.8+12.8, p = 0.005). 
The GRH program promotes improvement in various fitness, physical function, and QoL 
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CHAPTER I: INTRODUCTION 
 
Over the past few decades, the prevalence of breast cancer has continued to rise, with 
incidence predictions approaching 330,000 in the United States alone1.  Presently, 1 in 8 women 
will be diagnosed with BC during their lifetime, and in 2019, 42,000 women died from the 
disease in the U.S.1. 
 However, the 5-year survival rate for all breast cancer survivors (BCS) is as high as 
89.9% as of 2015, meaning that more people than ever are living with a history of the disease1. 
The issue arises from BCS  living with various deleterious side effects from the disease and 
treatments leading them to experience a lower level of quality of life (QoL) when compared to 
pre-cancer levels2. With this information, it seems more prescient than ever that survivorship 
issues should be a priority. Researchers need to think not only of how they can help patients 
reach the “No Evidence of Disease” stage, but what can be done for them during and post-
treatment to help them ease back into a “normal”, functional, healthy life.  
The side effects from chemotherapy, radiation, surgery, or any combination of the three 
are known to leave BCS feeling fatigued, in pain, depressed, anxious, and unable to function at a 
high enough level to complete their daily tasks3. In addition, adjuvant therapy such as hormonal 
therapy levied daily for years following treatment exacerbate treatment-related side-effects, 
compromising even further the QoL of survivors4. Following diagnosis, up to 90% of women 
experience at least one treatment-related side effect, while 60% experience multiple side effects 
which can severely impact QoL as well as survival rate5. Out of all common treatment-related 
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side effects, depressed aerobic capacity is a hallmark complication following cancer therapy and 
is of great concern because it has significant implications on QoL and long-term prognosis. In 
general, aerobic capacity is often 30% low in cancer survivors who undergo anti-cancer 
treatments6.  
Keeping in mind that the survival rate for all types of BC is nearly 90%, the focus must 
be shifted to interventions that can alleviate treatment-related side-effects, while promoting 
better health, and consequently decrease all-cause mortality4. Exercise has been shown to 
alleviate many cancer treatment-related side-effects, promote improvement in overall health, and 
be safe for most survivors who are cleared by their oncologists to engage in regular exercise7. 
Furthermore, engaging in physical activity on a regular basis has been shown to be protective for 
breast cancer, as the combined effects of being sedentary, having a poor diet, and being 
overweight appear to directly impact the development of 25-33% of all breast cancer; these same 
facts mentioned above are also postulated as factors increasing the risk of recurrence in BCS4. 
 Randomized controlled trials have supported the use of aerobic and strength training 
exercises for BCS as a safe and effective means of alleviating treatment related side effects8. 
Exercise guidelines for cancer survivors have recently been updated as a complementary therapy 
to the traditional treatment plans, which has led to increasing interest by the medical community 
for survivors to participate in exercise programs7.  
A community-based program called Get Real and Heel (GRH) on the campus of UNC-
Chapel Hill aims to ease the transition back into life post-cancer by offering moderate-to-
vigorous supervised exercise in a group setting for the improvement of fitness, health, and 
overall QoL of BCS. The GRH program offers exercise prescriptions tailored to each person on 




group setting of the exercise also fosters an environment where survivors can feel comfortable 
and at ease enough to take off their wig or prosthetics, and feel accepted by a group of people 
who understand their journey to get there. The aim of GRH is not only to increase physical 
function through structured endurance, strength, and flexibility exercises, but most importantly, 
create social capital between survivors and improve QoL.  
 In 2006, the year of its inauguration, the GRH program started as a 20-week exercise 
intervention where BCS exercised 1-on-1 with a personal trainer. Although survivors were 
finding a physical benefit from the training, they were still lacking the interpersonal connections 
of being surrounded by people who have undergone similar circumstances; the development of 
social capital. In 2013, GRH shifted its model to be a group-based exercise program to not only 
address the interpersonal issue, but to make the program more cost-effective and scalable for 
implementation in other universities and cancer centers. Now, at GRH, BCS workout together in 
groups of 5-10, not only allowing them to form a community of their own, but also allowing 
GRH to exponentially increase the amount of people it is able to serve, while maintaining the 
program free of cost to survivors.  
 The GRH program’s major goal is to improve the aerobic capacity of BCS, as well as 
their physical functioning, strength, and balance, as part of a comprehensive and individually 
tailored exercise program under the supervision of a personal trainer. These components of 
fitness cited above all play a role in a survivor’s QoL. While the GRH program has been 
operating in this manner for years with great satisfaction to its participants, it has yet to be 
empirically evaluated for its effectiveness on improving various components of fitness and 




As the world of cancer treatment begins to shift its focus to survivorship, GRH’s program 
format could shed light on a method of training that is both effective, scalable, and cost-effective, 
thereby setting a precedent to help thousands of cancer survivors in the U.S. and abroad. 
However, as previously mentioned, the GRH program’s effectiveness has yet to be 




The primary purpose of this study was to evaluate the effectiveness of the GRH 16-week 
community-based exercise program on factors influencing fitness (VO2peak, muscular strength, 
and body composition (Body Fat% [%BF]/Lean Body Mass [LBM])) and physical function (6 
Minute Walk Test (6MWT), Timed Up and Go (TUG), and balance) in BCS. The secondary 
purpose of this study was to evaluate patient reported outcomes (PROs) including overall QoL. 
PROs included fatigue, sleep quality, pain interference, applied cognition, and self-efficacy for 
physical activity measures using the PROMIS (Patient Reported Outcomes Management 
Information System) questionnaire, and an overall score of QoL assessed via the Functional 
Assessment of Cancer Therapy: General (FACT-G) questionnaire. The third purpose was to 
explore the relationship between changes in factors influencing fitness (VO2peak, muscular 
strength, and body composition), physical function (6MWT, TUG, and balance), PROs (fatigue, 
sleep quality, pain interference, and applied cognition and self-efficacy), and QoL. These 
exploratory analyses will help better inform how changes in physical function and PROs after a 
16-week exercise program at GRH are related to QoL in BCS, so specific interventions at GRH 
can be developed to target outcomes that have the greatest impact on QoL. The last aim, which 




the 16-week exercise program elicited different fitness, physical function, PROs, and QoL 
responses after patients were stratified into a low or high participation adherence to the exercise 
intervention.  
All variables along with form of measure can be seen in the table below: 
Table 1: Variables and Forms of Measure 
VARIABLE FORM OF MEASURE 
Body Fat %, Lean Body Mass DEXA 
Physical Function 6MWT, TUG, Sensory Organization Test 
(Balance) 
Fatigue, Sleep Quality, Pain Interference, 
Applied Cognition, Self-Efficacy 
PROMIS 
Quality of Life FACT-G 
VO2peak Cardio-Pulmonary Exercise Testing 
Muscular Strength Isometric Leg Extension, Isokinetic Leg 
Extension, Isometric Row (Dynamometry) 
     
Research Questions 
 
1) Is the GRH protocol effective in eliciting positive changes in fitness and physical 
function in BCS? 
2) Does GRH improve PROs in BCS?  
3) Does GRH improve QoL in BCS? 
4) Are changes in fitness, physical function, and PROs associated with changes in QoL? 
5) Did those subjects with higher adherence values see greater magnitudes of improvement 







H1a: Fitness parameters will improve in BCS following participation in a 16-week exercise 
intervention at the GRH facility. 
H1b: Physical function will improve in BCS following the participation in a 16-week exercise 
intervention at the GRH facility.  
H2: PROs will improve in BCS following participation in a 16-week exercise intervention at 
the GRH facility. 
H3: QOL will improve in BCS following participation in a 16-week exercise intervention at 
the GRH facility. 
H4: There will be a significant association between changes in fitness, physical function, 
PROs and QoL following participation in a 16-week exercise intervention at the GRH 
facility. 
H5: BCS with higher adherence to the 16-week exercise program will present with greater 













Table 2: Hypotheses and Corresponding Variables 
HYPOTHESIS VARIABLES 
H1a: Fitness parameters will improve in 
BCS following participation in a 16-week 
exercise intervention at the GRH facility. 
VO2peak, Muscular Strength, %BF/LBM 
H1b: Physical function will improve in BCS 
following the participation in a 16-week 
exercise intervention at the GRH facility. 
6MWT, TUG, Balance 
H2: PROs will improve in BCS following 
participation in a 16-week exercise 
intervention at the GRH facility. 
Fatigue, Sleep Quality, Pain Interference, 
Applied Cognition, Self-Efficacy 
H3: QOL will improve in BCS following 
participation in a 16-week exercise 
intervention at the GRH facility. 
Overall Quality of Life 
H4: There will be a significant association 
between changes in fitness, physical 
function and QoL following participation in 
a 16-week exercise intervention at the GRH 
facility. 
VO2peak, Muscular Strength, %BF/LBM, 
6MWT, TUG, Balance, Fatigue, Sleep 
Quality, Pain Interference, Applied 
Cognition, Self-Efficacy 
H5: BCS with higher adherence to the 16-
week exercise program will present with 
greater changes in magnitude of fitness, 
physical, PROs, and QoL. 
Low & High Adherence Quartiles, VO2peak, 
Muscular Strength, %BF/LBM, 6MWT, 
TUG, Balance, Fatigue, Sleep Quality, Pain 
Interference, Applied Cognition, Self-
Efficacy 
 
Definition of Terms 
 
• Adherence to the 16-week GRH exercise program was defined by stratifying BCS into 
both low and high adherence splits, as well as quartiles based on total planned exercise 
training days.  BCS who attended 75% or more of planned sessions were considered high 
adhering, and those below were low adhering. A second analysis was conducted using the 




adherence) and BCS falling into the highest quartile (high adherence) were used for 
analyses.   
• Get Real and Heel (GRH): An exercise facility on the campus of UNC-Chapel Hill that 
offers supervised group exercise sessions to BCS. 
• Breast Cancer (BC): A type of cancer beginning in the breast due to unmitigated cell 
growth. 
• Cardiopulmonary Exercise Testing (CPET): A test used to assess the integrative system 
(pulmonary, cardiovascular, skeletal systems) response to an increasing intensity of 
exercise on a cycle ergometer or treadmill.  
• Sensory Organization Test: A form of balance test which uses visual, proprioceptive, and 
vestibular cues to maintain stability while standing. 
• 6-Minute Walk Test (6MWT): A walking test used to assess aerobic endurance and 
functionality by measuring how far a subject can walk in meters in a 6-minute time 
frame.  
• Timed Up & GO (TUG): A functionality test which measures agility and dynamic 
balance by timing how long it takes for a subject to rise from a chair, walk around a cone 
placed 8 feet away, and return to the chair.  
• Rating of Perceived Exertion (RPE): A scale numbered 6-20 used to assess a difficult an 





• Subjects had non-metastatic BC, and completed all primary cancer treatments within the 




• Subjects were recruited from UNC Hospitals and surrounding medical institutions.   
• Subjects engaged in exercise (aerobic, strength) 3 days per week for 16 weeks at the 
GRH exercise facility on the campus of UNC-Chapel Hill. Exercise sessions lasted 
approximately 1 hour  
• Exercise days were Monday, Wednesday, and Thursday 
• Subjects began the intervention at different ability levels, with the goal of completing 30 
minutes of aerobic exercise, and 30 minutes of muscular strength training, but exercises 
were tailored to engage at intensities relative to their fitness level  
• Subjects were excluded if they did not have a history of cancer, or had not completed all 
primary treatments within 1 year since starting the study  
• After completing all physical function testing, subjects could be deemed not medically 
suited to participate in the GRH protocol, at the discretion of the investigators  
• This was a 1-arm study, so all subjects participated in the exercise intervention  
• Rating of Perceived Exertion (RPE): A scale numbered 6-20 used to assess a difficult an 





• Subjects were recruited from UNC Hospitals and surrounding areas, so subject 
participation cannot be deemed truly random, limiting generalization of the study results   
• Subjects underwent various types and combinations of treatment protocols 
• Subjects entered the study at different levels of exercise ability, so their response to the 




• Subjects were expected to exercise at the facility 3 days per week, however the facility is 
only open on 3 days. Therefore, exercise could not be rescheduled if there is a conflict.  




• BCS will adhere to all pre-testing guidelines. 
• BCS will engage in increasing levels of intensity and duration as the study prescription 
progresses. 
• BCS will maintain normal exercise/lifestyle habits outside of GRH for the duration of the 
study period. 
 
Significance of Study 
 
This study was unique/novel in that it evaluated the effectiveness of an exercise 
intervention program that is quite uncommon (community-based exercise program for cancer 
survivors), yet well-functioning. Currently, there are highly-controlled, laboratory-based exercise 
trials, and there are time-limited community-based exercise programs for cancer survivors. The 
GRH program is one of very few community-based exercise programs in the world that offers 
supervised exercise training in a group format for BCS. As the survivorship pool grows, more 
real-world settings such as GRH will be necessary to accommodate long-term needs of a large 
number of survivors. Evaluating the effectiveness of a real-world exercise intervention designed 
to assist BCS with the alleviation of disease and treatment-related side-effects, while also 
providing survivors with the best chance to improve their health and have the best QoL in the 




how to best develop their exercise interventions so they are aimed to maximize fitness, physical 




























 More than 17 million new cancer cases were diagnosed in 2018 worldwide, with more 
than 2 million of those cases being attributed to breast cancer9. It is expected that the United 
States will see greater than 1.7 million new cases of cancer, with breast cancer contributing more 
than 268,000 to that total1. More than 600,000 people will die from cancer, and of that total, 
approximately 41,000 will be due to BC1. In some countries, the leading cause of death for 
women between the ages of 40-60 is breast cancer, but thanks to improvements in detection and 
treatment strategies, mortality rates are on the decline, with some projections indicating that 3 
out of 4 BC survivors will be 65 years old or older by the year 204010,11. This number is 
significant because it means that as more people survive the disease, some of the focus should be 
shifted toward survivorship.  
 




Cancer is a disease characterized by the unmitigated growth of abnormal cells1. 
According to one review, one of the most fundamental traits of a cancer cell is its ability to 
control its own proliferation by deregulating signals that would cause the normal production of 
growth-promoting signals, and the absence of negative feedback loops that would under normal 
circumstances act to ensure homeostasis12. This same review revealed the 6 “Hallmarks of 
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Cancer,” which include a cell’s ability to sustain proliferative signaling, evade growth 
suppressors, activate invasion and metastasis, enable replicative immortality, induce 
angiogenesis, and resist cell death12. In breast cancer, these cells can begin multiplying in the 
ducts that carry milk to the nipple, the glands that make breast milk, or the breast tissue itself13. 
 
Treatment for Breast Cancer 
 
 Treatment for breast cancer can involve several possible combinations of treatment 
options, including surgery, radiation, chemotherapy, or a combination of the three. Locally, 
surgery can be used in order to remove as much of the cancer as possible, via lumpectomy or 
mastectomy13. Some surgeries, such as lymph node biopsies or dissections, are performed in the 
underarm area in order to evaluate if the cancer has spread to the lymph nodes, thereby 
indicating just how far the cancer has spread outside of the breast13. 
 Another form of local treatment for breast cancer is radiation, which employs high energy 
particles to eliminate cancer cells13. Radiation acts to lessen the possibility of cancer returning in 
the originating breast, or in lymph nodes that may have been affected, and may also be used if 
the cancerous tumor was greater than 5 centimeters or spread to several lymph nodes13. 
 Systemically, chemotherapy can be used after surgery (adjuvant) or before surgery 
(neoadjuvant). Adjuvant chemotherapy is sometimes used to make certain all cancer cells have 
been destroyed, even those which are undetectable, while neoadjuvant chemotherapy is used in 
order to shrink the tumor prior to surgery to make its excavation less extensive13. Some of the 









Life as a cancer survivor can mean dealing with the myriad side effects that come along 
with a standard treatment for cancer. In breast cancer, it can mean scarring, pain, and immobility 
from surgery, anxiety and depression, nausea and vomiting, skin changes, weight change, higher 
risk of infection, and elevated levels of fatigue which is seen in 99% of women who undergo 
chemotherapy10,13. In many cases, fatigue levels become so debilitating that the patient becomes 
inactive, leading to stress, poor sleep, and poor physical conditioning, thereby causing more 
fatigue in a positive feedback system10.  
Cardiorespiratory function is severely declined in cancer patients, with VO2peak values 
falling 30% lower than age-matched, sedentary people without a history of cancer, which could 
be attributed to the toxic effects of cancer treatment that damage the cardiovascular system and 
impact the systems that affect an individual’s capacity to exercise14. Certain chemotherapies, 
such as trastuzumab, can cause left ventricular remodeling, and decrease oxygen delivery to 
exercising muscles via decreased ejection fraction15. In addition to Cardio-Pulmonary Exercise 
Testing (CPET), aerobic endurance can be measured via the 6MWT. Schmidt et al found that 
6MWT distances of cancer patients correlated significantly with exercise capacity measured via 
VO2peak, maximum workload in Watts, and perceived physical function, and among trials in 
cancer patients most studies reported an increase of more than 5.2% from pre to post testing16. 
This trial also displayed acceptable test-retest reliability in cancer patients16. 
 
Exercise as an Alternative Therapy 
 
Unfortunately, completing primary treatment for cancer does not mean that the journey 




much of their life. In addition to the immediate treatment related side effects comes the increased 
risk for other comorbidities to develop, such as cardiovascular disease, diabetes, osteoporosis, 
and sarcopenia3. In fact, cardiovascular disease in cancer survivors is now a leading cause of 
death along with recurrence of cancer. In a 2011 comorbidity review that included more than 
63,000 subjects, only 15.1% of the study population died due to BC, while 36.2% died due to 
other causes; cardiovascular disease accounted for a 59.2% increase in chance of death, and 
diabetes came in at 47.8%, both of which were higher than having a previous cancer (43.8%)17. 
For a long time, exercise was not considered as part of the post-treatment process. It 
wasn’t until the 1990’s that research in exercise began to challenge some of the long-held beliefs 
that rest was key to recovery, and to this day health care providers do not prescribe exercise as a 
standard of care for patients and survivors; 1 in 10 professionals still believe that rest is more 
important than physical activity7,10. In 2012, the American College of Sports Medicine developed 
the first guidelines for exercise for people with cancer18. Exercise intervention studies were more 
difficult to come by at that time, but they were able to conclude that exercise was “generally safe 
and well tolerated” for survivors, and physical activity could improve variables such as fitness, 
physical function, QoL, and cancer-related fatigue7. Due to the small amount of evidence, those 
exercise guidelines were not far different from the exercise guidelines set forth for adults. 
However, the past decade of work allowed for more specific exercise prescriptions to be formed 
which could target specific outcomes, showing the growing appreciation for the need to 
individualize treatment. With the more than 2,500 publications that have arisen in the interim, a 
second roundtable of the ACSM was able to advance those guidelines based on cancer type, and 




 CPET, which is a gold standard used to measure a person’s aerobic capacity described in 
volume of oxygen consumed (VO2), also happens to be a reliable predictor of both QoL and 
morbidity in women who have undergone standard treatment for breast cancer, specifically 
adjuvant and neo-adjuvant therapies19. Physical activity in BCS overall is much lower than the 
general population, with only 8% of survivors meeting aerobic activity guidelines, and peak 
oxygen consumption levels approximately 30% lower than healthy, even sedentary women14,19. 
Exercise is a known promoter of improved cardiorespiratory fitness in healthy individuals, and 
research has shown that its benefits extend to cancer survivors as well7. Unfortunately, physical 
activity is not always recommended as part of the recovery process by health care providers, and 
even when patients are motivated to make more positive lifestyle choices, exercise 
encouragement from a provider might still be necessary in order for those choices to be 
realized20. One study looking at Moderate-Vigorous Physical Activity showed that a high 
number of BCs are inactive, and without the use of an exercise intervention, survivors are highly 
unlikely to change their current levels of physical activity21. As it has been seen in numerous 
studies, the safety and efficacy of exercise post-treatment is safe and well-tolerated, with 
survivors who are physically active showing significantly higher QoL measures compared to 
those who are more inactive7,20. Increased physical capacity allows individuals to engage in daily 
activities that promote independence and leave them feeling more satisfied with their lives. In 
fact, survival and total mortality risk has been tied to the amount of exercise performed; each 10 
MET task-hours per week increase in activity following diagnosis was associated with a 24% 
decrease in mortality, and for those who were sedentary pre-diagnosis, any increase in physical 





Exercise and Physical Function  
 
 One meta-analysis by Jones et al. showed that a supervised exercise training intervention 
elicited statistically significant increases in VO2peak, while a non-exercise control group 
correlated to a decrease in VO2peak14. A meta-analysis by Fong et al. revealed that exercise 
interventions elicited a statistically significant increase (2.2 ml/kg/min) in peak oxygen 
consumption, and peak power output (21.0 Watts)22. McNeely et al. had pooled results showing a 
3.39 ml/kg/min improvement in oxygen consumption values23. These findings cannot be 
understated, as oxygen consumption values are reliable predictors of all-cause mortality. An 
increase of just 1 MET in exercise capacity corresponds to a reduced risk of death by 17%, as 
shown by the Framingham Risk Score; a measure of cardiovascular related illness24. In fact, 
studies in older adults, and women in particular, yielded a VO2 of ~15ml/kg/min necessary to 
maintain independent living, and many cancer patients do not meet that criteria14,25. Being that 
by 2040, 3 out of 4 cancer survivors will be 65 years or older, this is of critical importance.  
 In terms of more basic forms of physical function testing, Fong et al. showed an increase 
of 29 meters post-intervention in the 6MWT22. A second review showed similar improvements, 
with an increase of 28 meters11. Rajotte et al. reported an increase of 37 meters in the 6MWT 
following a 12-week group exercise intervention for survivors26. A 2017 meta-analysis on 
physical function in BCS showed that all results favored the exercise group over the control 
group in improvements in physical function, regardless of the time of the intervention, or the 
type of adjuvant therapy10. A 2006 review had pooled results which showed statistically 
significant improvements in favor of the exercise group for the 6MWT, 12-Minute Walk Test, 




Physical activity has been shown to increase physical function in cancer survivors, across 
all modes of exercise. A 2016 Cochrane Review showed that muscular strength was significantly 
improved following an exercise intervention that included resistance training27. A 12-week group 
exercise intervention by Rajotte et al showed a statistically significant increase in upper and 
lower body strength scores using a 1 repetition maximum test26. A second systematic review 
evaluated strength gains and changes in lymphedema incidence following resistance training. 
This review showed that there is strong evidence that moderate-high intensity resistance training 
provides significantly greater gains in strength than a non-exercise group, all without the 
exacerbation of breast cancer related lymphedema symptoms28. Besides strength gains, low-
intensity resistance training for the shoulder coupled with flexibility exercises provoked 
significant strength gains in flexion and abduction movements compared with non-exercise 
groups, two traditionally difficult or painful movements for many BCS28. This same review 
showed that those subjects who performed resistance exercises on 2-3 non-consecutive days had 
significantly greater strength gains compared to controls, with no exacerbation of symptoms 
regardless of the resistance training protocol that was used28. These strength gains are important 
to improving a survivor’s ability to complete their activities of daily living and maintain 
independence. 
 
Quality of Life 
 
 With increasing numbers of breast cancer survival, the quality of life post-treatment is 
now more of an issue than ever before. BCS deal with anxiety, fear of recurrence, problems with 




 Rajotte et al. saw improvements in all Patient Reported Outcomes (PRO) measures 
except for muscle cramps following a 12-week exercise intervention that included aerobic and 
resistance exercises26. Improvements were elicited in physical function, general health, mental 
health, social function, social support, body pain, fatigue, and insomnia26.  
 A 2017 meta-analysis including 17 randomized controlled trials showed that exercise was 
shown to reduce fatigue when compared to conventional care, and although a combination of 
aerobic and resistance training has the most benefit, a moderate intensity resistance protocol of 
3-6 METs or 60-80% of 1 Rep Maximum was able to reduce cancer related fatigue more than 
lower intensity resistance or aerobic exercise10. 
 Fong et al. showed that results favored the exercise intervention when measuring fatigue 
via the Piper Fatigue scale, depression measured with the Beck depression inventory, and 
improvements in mental health and social function22. Another review from McNeely et al. 
showed that pooled estimates resulted in statistically significant improvements in QoL by a 
magnitude of 4.0 on the FACT scale, which deems it clinically meaningful due to exercise23. 
Pinto et al. studied the link between physical activity and psychosocial benefits in breast cancer 
patients. They found that those women who adopted physical activity into their lifestyle saw 
significant improvements in QoL versus those who never adopted physical activity at a 3-month 
follow up, and those who maintained 150 min/week reported less fatigue, higher physical 
functioning, and improved QoL 6 months later compared to non-adopters29. 
 The 2019 Exercise Guidelines for Cancer Survivors showed that a combination of aerobic 
and strength training done 2-3 sessions/week for at least 12 weeks can improve QoL whether 
done during or after treatment, and the combination of an aerobic regimen with a strength 




Community Based Exercise 
 
 Being a BCS brings with it a host of problems, and while exercise can help alleviate 
those burdens, patients have identified certain barriers to exercise such as cost, lack of 
accessibility, transportation, safety concerns, and negative attitudes toward exercise among other 
things3,4. However, healthcare providers can help promote exercise a part of a rehabilitation plan 
that includes an exercise professional who can provide appropriate supervision, and an exercise 
program that is part of the same institution that administered the treatment4. Another important 
facilitator to exercise and physical activity is a group-based program that remains individually 
prescribed, with slow, gradually progressing exercise3. With this, improvements in physical 
function were seen when aerobic and resistance training were done 3 times/week for 8-12 weeks, 
with more effective training coming under the supervision of a professional as opposed to an at-
home intervention. 
 Community-based exercise interventions can also help in overcoming barriers to exercise 
by providing exercise in a more “real-world” setting, and not relying on the high-cost, high-
resource design of a randomized controlled trial11. This can enhance a patient’s sense of 
behavioral control, and a positive setting combined with a like-minded group can aid in creating 
a positive attitude and subjective norms3. A systematic review and meta-analysis in 2017 
identified that all of the studies identified for the review that had “supervised exercise” held 
sessions twice per week in conjunction with home-based exercise, and had both aerobic and 
strength training as part of the protocol11. This same review found that for 6MWT values, 
community-based exercise interventions that met in groups had the largest effect size, along with 




cancer survivors is a protocol that includes group-based intervention and cognitive behavioral 
therapy11.  
 A 2011 study conducted group exercise sessions for cancer survivors at local YMCAs. It 
found that a group-based format with personal trainer supervision meeting 2 days/week elicited 
positive changes in fatigue, insomnia, physical function, mental health, social support, and 
general physical activity26. These patients participated in a 12-week intervention, but still had 
access to the facility and trainers at the end of their study period. It should be noted that personal 
trainers in the program had to possess at minimum 1 year of personal training experience, and a 




 The results of these studies and reviews have shown that exercise in any form is a safe 
and effective way for cancer survivors to manage their symptoms, and improve their physical 
function and QoL. However, much of this work has been done in highly controlled laboratory 
trials, and with the growing demand that is coupled with increased survival, it is important to 
investigate if community-based group programs can offer as effective an intervention. A 
community-based program will trade off internal validity for external validity, but an evaluation 
of a program such as GRH could help discover if this form of exercise intervention is effective, 
scalable, and cost-effective. It has also been seen in the literature that supervised group exercise 
has more benefits than laboratory trials or at-home interventions. Supervision by a trained 
professional allows for detailed manipulation of the exercise protocol in order to fit each 




and effective interventions30. Besides this, the group atmosphere can offer more comfort and 
motivation in the exercise space.  
GRH offers small group (5-10 persons) exercise sessions, lasting 60 minutes in duration, 
under the supervision of a trained professional, for 3 sessions per week. Survivors are free to 
exercise in facility which is available only to cancer survivors, for as long as they choose at no 
cost to them.  
By offering a free, easily accessible, individually tailored program via the UNC-Cancer 
Hospital, GRH can evaluate if the protocol in use offers safe and effective exercise classes to the 
masses, thereby helping survivors take control of their own healthcare, and possibly drive down 
future healthcare costs. Cost projections for 2020 show that breast cancer is among the cancers 
with the highest increase in cost for the continuing care phase of life in the past decade, 
increasing 32% from 2010 projections31. A low-cost, scalable, and effective exercise program 
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 This study included females who had been diagnosed with early stage (non-metastatic) 
breast cancer, and had completed primary treatment within the past 1 year. Participants were 
permitted to be on continuing hormone therapy. Participants were not be permitted to take part in 
the study if they possessed any physical ailments which could have precluded them from 
participating in a moderate-intensity exercise program, as decided by the study investigators or 
the subject’s medical team. Subjects were not included if they had not completed surgery, 
radiation, or chemotherapy, or if their doctor had not cleared them for activity. Subjects could 
not participate if they had previously completed the GRH exercise program. All participants 
were required to sign an IRB approved written informed consent, and agreed to take part in the 





 This study was a 1-arm intervention designed to evaluate the effectiveness of the GRH 
exercise program in improving fitness, physical function and QoL in BCS. Participants were 
required to attend 2 days of pre-testing, followed by a 16-week exercise intervention at the GRH 
facility. At the completion of the 16-week intervention, the participant underwent 2 days of post-
testing following the exact format of pre-testing. All testing was performed in the UNC Exercise 
Oncology Research Laboratory, the UNC Sports Medicine Laboratory, and the Matthew Gfeller 
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Sport-Related TBI Research Center. Pre-testing was completed within 2 weeks of beginning the 
GRH program, and post-testing was completed within 2 weeks of completion. Subjects 
underwent testing for the following variables in this order: body composition for the evaluation 
of %BF and LBM, physical function testing including 6MWT and TUG, PROs (fatigue, sleep 
quality, pain interference, applied cognition, and self-efficacy), QoL, Sensory Organization 
Testing (SOT) for balance, VO2peak, and muscular strength.  
 Body composition was evaluated first on Day 1 of testing, before the subject had 
participated in exercise. Because the 6MWT is a functional test of endurance, it was performed 
prior to the TUG test, which measures a subject’s agility and dynamic balance. PROs and QoL 
questionnaires were taken home at the end of Day 1 to be completed by the subject at their 
leisure, in order to ascertain more reliable answers. Because muscular strength for lower body 
exercises were unilateral, Day 2 began with VO2peak testing on a cycle ergometer to ensure that 
the leg tested for strength is not more fatigued than the non-tested leg prior to cycling. 
 
Table 3: Day of Testing with Testing Measures 
TEST DAY 1 DAY 2 
%BF, LBM X  
6MWT X  
TUG X  
PROs X  
QoL X  
VO2peak  X 






The exercise intervention progressed from low to moderate intensity over the course of 
16-weeks. Aerobic exercise was performed on either a treadmill, bicycle, elliptical, rower, or 
seated stepper, and began at a duration of 10-15 minutes with a rating on the Borg Rating of 
Perceived Exertion Scale (RPE) of 8-11. The eventual goal was for subjects to reach 30 minutes 
of continuous aerobic exercise, with a corresponding 12-14 on the RPE scale.  
 Resistance training exercises were done in correspondence with the previously described 
aerobic exercise, and consisted of 6 exercises done 3 times per week, focusing on all major 
muscle groups. Training began with 10-15 repetitions done for only 1 set, with a corresponding 
7-13 on the RPE scale for the first 2 weeks. Weeks 3-5 required a progression in intensity, 
bringing the RPE number to 14-15, as well as an increase to 2 sets for each exercise. Balance 
was incorporated into resistance training exercises. Training sessions were monitored by all staff 
members, with safety and correct form of the utmost priority. Figure 1 shows a breakdown of 













Figure 1: Aerobic and Strength Intervention Baseline and Progression 
 
For this study, the independent variables were pre and post exercise intervention, while 
the dependent variables were the change scores of all measures of fitness, physical function, 
PROs, and QoL.  
 
VO2peak (Cardiorespiratory Function) 
 
 VO2peak, considered the “Gold Standard” for assessing aerobic fitness, was assessed on an 
electronically braked cycle ergometer (Lode, Gronigen, The Netherlands) during day 2 of 
pre/post testing. Subjects were familiarized prior to testing to control for the learning effect. 
Testing utilized a continuous incremental ramp protocol which followed ACSM testing 
guidelines; breath by breath metabolic analysis was used to determine oxygen consumption via 
Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, Salt Lake City, UT USA.)  
 The test began with the subject sitting quietly on the cycle ergometer, allowing 
researchers to collect resting metabolic data. The first stage of testing was an unloaded 2-minute 
warm-up, with 0 Watts on the ergometer, followed by a 3-minute loaded warm up at 20 Watts. 




until the test was completed. Heart rate readings and RPE values were collected continuously 
throughout the test. Test termination was reached in one of the following ways: the subject 
reached volitional exhaustion and signaled their intent to stop, there was a VO2 plateau or 





 Muscle strength was evaluated using the HUMAC Norm Dynamometer (Computer 
Sports Medicine, Inc., Stoughton, MA, USA) in the UNC Sports Medicine Laboratory. Peak 
torque of the vastus lateralis was assessed using isokinetic and isometric leg extension. Upper 
body strength was assessed via peak torque of an isometric row.  
 The isokinetic leg extension was evaluated at 60°/second. Subjects began by being 
harnessed into a chair, with straps placed over the shoulders, waist, and right leg. When the 
subject was properly placed, they performed 3 warm-up leg extensions at 50% of their perceived 
max. Following the warm-up, subjects performed 3 isokinetic leg extensions as fast as possible, 
with 3 minutes of rest between each trial. The highest torque recorded during the 3 trials was 
used in the data analysis, which was measured using a BIOPAC MP150 (BIOPAC Systems Inc., 
CA, USA).  
 Isometric leg extensions were performed with the arm of the dynamometer locked in 
place, with the subject’s anterior tibialis perpendicular to the floor. Subjects were asked to extend 
their leg as hard as possible against the immovable arm for 3-4 seconds. The subject performed 
isometric leg extensions for 3 trials, with 3 minutes of rest between each trial. The highest peak 




 The isometric row was performed with the subject in an upright seated position, secured 
to the chair. The subject was placed with their elbows bent 90° with their arms at their side, and 
hands pronated, gripping a horizontal bar. Two to three warm-ups were performed before testing. 
Upon testing, the subject pulled straight back as hard as possible, for 3-4 seconds. After three 




 Body Composition analysis was conducted using Dual X-ray Absorptiometry (DEXA), 
which is considered a reliable and valid means of assessing %BF and LBM32. A Hologic 




 Functionality was assessed using the 6MWT, the TUG, and the SOT for balance.  
6MWT was used to measure aerobic endurance, and is considered a valid and reliable 
measure to use in cancer patients33. This test utilized a 50-yard course which was marked in 5-
yard increments. Subjects had six minutes to walk as far as possible, with no jogging or running 
allowed. Researchers estimated the total distance to the nearest 5-yard increment, which was 
then converted to meters.  
 TUG testing assessed dynamic balance and agility, and is a valid and reliable test in 
cancer survivors34. The subject began by sitting in a chair placed securely against a wall, with 
their hands on their thighs. When signaled to begin, the subject rose from the chair, walked 
around a cone placed eight feet away, and returned to a seated position in the chair as fast as 




 Balance and postural stability were evaluated using a SOT via the Neurocom Balance 
Master (Neurocom International Inc., OR, USA). Dual force plates assessed the visual, 
somatosensory, and vestibular systems over 18 trials in 6 different conditions. 
 The balance tasks were assessed in random order and included the following conditions: 
1. Eyes open, stable surface 
2. Eyes closed, stable surface 
3. Eyes open, stable surface, visual surround disturbance 
4. Eyes open, unstable surface 
5. Eyes closed, unstable surface 




Each trial lasted 20 seconds, with 5 seconds of rest between each trial. Trials conditions were 





PROs and QoL 
 
PROs included fatigue, sleep quality, pain interference, applied cognition, and self-
efficacy for physical activity measures using the PROMIS questionnaire, and an overall score of 
QoL was assessed via the Functional Assessment of Cancer Therapy – General (FACT-G). 
PROMIS measures have been validated in clinical populations35. The FACT-G is a questionnaire 
that relies on self-report with the subsections divided into physical well-being, social/family 
well-being, emotional well-being, and functional well-being. The FACT-G has been shown to be 




This one-arm study consisted of one group assigned to a 16-week exercise intervention. 
All recorded data was entered into an electronic database and analyzed using SPSS Version 20.0 
(Chicago, IL) for Windows; an alpha level of 0.05 was used for all analyses. Descriptive 
statistics were computed and were presented in the form of means ± standard deviation (SD) for 
quantitative variables and frequencies for categorical variables. Confidence intervals of the 
means were also reported, as well as effect size calculations.  The effect size of each t test 
analysis was computed via the Cohen’s d method (small effect size, d = .2 - .5: medium effect 
size, d = .5 - .8: large effect size, d  > .8)32 
 
Hypothesis 1a:  Fitness parameters will improve in BCS following participation in a 16-week 
exercise intervention at the GRH facility. Pre and post intervention evaluation of fitness parameters 




composition (%BF and LBM) were analyzed using change scores, utilizing dependent samples t-
tests.   
 
Hypothesis 1b: Physical function parameters (6MWT, TUG, and balance) will improve in BCS 
following participation in a 16-week exercise intervention at the GRH facility. Pre and post 
intervention physical function parameters were analyzed using change scores, utilizing dependent 
samples t-tests.  
 
Hypothesis 2: PROs will improve in BCS following participation in a 16-week exercise 
intervention at the GRH facility. PRO parameters including fatigue, sleep quality, pain 
interference, applied cognition, and self-efficacy were analyzed using change scores, utilizing 
dependent samples t-tests.  
 
Hypothesis 3: QoL will improve in BCS following participation in a 16-week exercise 
intervention at the GRH facility. QoL evaluated via the FACT-G was analyzed using change 
scores, utilizing dependent samples t-tests. 
 
Hypothesis 4: There will be a significant association between changes in fitness, physical 
function, PROs and QoL following participation in a 16-week exercise intervention at the GRH 
facility. The relationship between fitness parameters including VO2peak (mlO2/kg/min), strength 
(peak torque), and body composition (%BF and %LBM) and physical function parameters 




efficacy), and QoL was analyzed using change scores, utilizing simple regressions with QoL 
being the dependent variable. 
 
Hypothesis 5: BCS with higher adherence to the 16-week exercise program will present with 
greater changes in magnitude of fitness, physical function, PROs, and QoL. Adherence to the 16-
week GRH exercise program was defined by stratifying BCS into low and high adherence, as 
well as a second analysis using the lowest and highest quartiles of adherence based on total 
planned exercise training days. A value of 75% or lower was considered low adherence, and 
anything above 75% was considered high adherence. There were 15 subjects in the Low 
Adherence group, and 17 subjects in the High Adherence group. Dependent samples t-tests were 
used for each variable within each group. For the quartile analysis, there were 8 subjects in the 
low adherence group (62% or below), and 9 subjects in the high adherence group (87.5% or 

















CHAPTER IV: RESULTS 
 
 The purpose of this study was to examine the effects of a 16-week exercise intervention 
on factors influencing fitness and physical function in a BCS population. A secondary purpose 
was to determine if the exercise intervention had an effect on PROs and overall QoL. The third 
purpose of the study was to determine the relationship between changes in fitness, physical, 
function, PROs, as a predictor of overall QoL. Finally, an exploratory aim of the study was to 
determine if adherence rates of low and high attendees showed a difference in magnitude of 




 A total of 35 BCS participated in the study. Thirty-two of those subjects completed the 
entire 16-week intervention and were included in analyses, while three were not. Charcteristics 
of the subjects are presented in Table 1 below, in the form of means + standard deviations. 
Overall adherence to the intervention for those who completed all 16 weeks was 72.14%. 
Additionally, only 31 subjects were used to assess VO2peak, as one subject was unable to 







Table 4: Subject Characteristics; n = 32 (mean + SD) 
Age (years) 53.8 + 11.7 
Height (cm) 167 + 7.1 
Pre Weight (kg) 76.3 + 12.3 
Post Weight (kg) 76.4 + 12.4 




Surgery Only 3 




 Pre and post intervention means + SD, change scores, p-values, lower and upper 












Table 5: Primary Outcomes (mean + SD) 









%BF 40.6 + 5.7 40.3 + 5.9 -.3 0.53 -0.7 1.4 0.1 
LBM 42.2 + 5.9 42.5 + 5.6 0.3 0.51 -1.1 0.6 0.1 
VO2peak 20.9 + 5.2 22.2 + 5.4* 1.3 0.04 -2.5 -0.0 0.4 
ISOK LE 80.2 + 20.5 76.9 + 25.3 -3.3 0.48 -4.1 8.7 0.1 
ISOM LE 101.0 + 26.3 111 + 31.9* 10.0 0.001 -17.3 -4.7 0.6 
ISOM Row 61.5 + 22.4 62.9 + 19.2 1.4 0.59 -7.8 4.5321 0.1 
6MWT 536.0 + 72.0 570 + 76.0* 34.0 <.001 -52.4 -17.0488 0.7 
TUG 4.8 + 1.2 4.26 + 1.3* -0.57 0.004 0.2 0.9333 0.5 
BalComp 71.7 + 11.6 76.5 + 10.5* 4.8 0.003 -8.144 -1.7919 0.6 
* p < 0.05 from pre to post intervention 
VO2peak (ml*kg-1*min-1); ISOK LE (Peak Torque); ISOM LE (Peak Torque); ISOM Row (Peak 
Torque); 6MWT (meters); TUG (seconds) 
(small effect size, d = .2 - .5: medium effect size, d = .5 - .8: large effect size, d  > .8) 
 
 
 Hypotheses 1a & 1b, which stated that fitness and physical function parameters would 
improve in response to 16-weeks of training at the GRH facility, were evaluated using dependent 
samples t-tests. Significant improvements were seen in VO2peak [ml*kg-1*min-1] (p = 0.044) with 
a small effect size of 0.4, isometric leg extension (p = 0.001) with a medium effect size of 0.6, 




medium effect size of 0.5, and balance composite scores (p = 0.003), with a medium effect size 
of 0.6. 
 The figures below illustrate the differences in means for pre and post testing. 
 
Figure 2: Pre and Post Intervention Values: VO2 (ml*kg-1*min-1) 
 



















































Figure 3: Pre and Post Intervention Values: Isometric Leg Extension (Torque) 
 
 




Figure 4: Pre and Post Intervention Values: 6MWT (meters) 
 
 


















































Figure 5: Pre and Post Intervention Values: TUG (seconds) 
 
 
* p < 0.05 from pre to post intervention 
 
 
Figure 6: Pre and Post Intervention Values: Balance (composite score) 
 
 
* p < 0.05 from pre to post intervention 
 
 
Factors Affecting Quality of Life 
 
 Pre and post intervention means + SD, change scores, p-values, lower and upper 


















































Table 6: Secondary Outcomes (mean + SD) 






Fatigue 16.6 + 4.89 15.9 + 4.1 -0.7 0.092 -0.2 2.1 0.3 
Pain 11.5 + 6.7 10.8 + 4.5 -0.7 0.408 -1.5 3.5 0.2 
AppCog 64.6 + 29.4 59.5 + 24.1 -5.1 0.100 -1.2 13.2 0.3 
SEPA 16.0 + 4.5 17.0 + 3.1 1.0 0.298 -2.6 0.8 0.2 
ISSI 8.7 + 5.4 7.1 + 4.5* -1.6 0.012 0.4 2.9 0.5 
QoL 82.6 + 13.0 84.8 + 16.4 2.2 0.314 -8.5 2.8 0.2 
* p < 0.05 from pre to post intervention 
(small effect size, d = .2 - .5: medium effect size, d = .5 - .8: large effect size, d  > .8) 
 
Hypotheses 2 & 3, which stated that PROs and QoL would improve in response to 16-
weeks of training at the GRH facility, respectively, were evaluated using dependent samples t-
tests. Significant improvements were seen in ISSI (p = 0.012), with a medium effect size of 0.5. 
It is important to note that scores for all variables, with the exception of applied cognition, 
trended in the direction of improvement. 
 
Relationship Between Changes in Fitness, Physical Function, PROs, and QoL 
 
 Hypothesis 4 stated that there would be a significant association between changes in 









Table 7: Relationship of Change Scores on QoL Change 
Variable p-value 95% C.I. Lower 95% C.I. Upper 
%BF Change .770 -2.3 1.7 
LBM Change .153 -3.7 0.6 
VO2 Change .492 -1.2 2.4 
ISOK LE Change .407 -.5 .2 
ISOM LE Change .622 -.2 .1 
ISOM Row Change .548 -.4 .2 
6MWT Change .684 -.1 .1 
TUG Change .323 -8.5 2.9 
Balance Change .638 -1.0 .6 
Fatigue Change .285 -3.3 1.0 
Pain Change .149 -2.2 .4 
AppCog Change .998 -.4 .4 
SEPA Change .044* .1 3.7 
ISSI Change .277 -3.0 .9 
* p < 0.05 from pre to post intervention 
 
 Of all variables measured, only a change in ISSI was associated with a change in overall 
QoL when baseline scores were controlled for. All other variables were not good predictors of 
change in QoL from pre to post intervention. 
 
Analysis of Magnitude of Change in All Variables in Response to Low and High Adherence 
 
Hypothesis 5 stated that survivors with higher adherence to the 16-week intervention 




For this analysis, low adherence was considered 75% (n = 15) attendance or lower, with high 
adherence being anything above 75% (n = 17). Dependent samples t-tests were used for each 
adherence group. 
 Pre and post intervention means + SD, change scores, p-values, lower and upper 
confidence intervals, and effect sizes of all secondary outcomes are presented in Table 8, below: 
 
Table 8: Adherence Comparison (mean + SD) 










%BF (Low) 38.7+5.67 39.1+6.2 0.4 0.583 -1.7 1.0 0.1 
%BF 
(High) 
42.3+5.3 41.3+5.7 -0.9 0.247 -0.7 2.6 0.3 
LBM (Low) 43.3+5.2 43.0+5.8 -0.4 0.503 -0.8 1.5 0.2 
LBM 
(High) 
41.2+6.4 42.1+5.6 0.9 0.191 -2.2 0.5 0.3 
VO2 (Low) 21.5+5.8 22.9+5.9 1.4 0.139 -3.3 1.5 0.2 
VO2 (High) 20.5+4.9 21.6+5.12 1.2 0.187 -2.9 0.6 0.3 
ISOK LE 
(Low) 
82.5+22.6 80.0+24.8 -2.5 0.569 -6.7 11.7 0.2 
ISOK LE 
(High) 
76.3+17.6 74.3+26.1 -2.1 0.658 -7.7 11.9 0.1 
ISOM LE 
(Low) 
99.8+30.0 115.0+34.7* 15.2 0.008 -25.7 -4.8 0.8 
ISOM LE 
(High) 






61.5+27.6 64.3+21.4 2.8 0.565 -13.2 7.5 0.2 
ISOM Row 
(High) 
61.1+18.7 61.8+17.7 0.7 0.863 -9.2 7.8 0.0 
6MWT 
(Low) 
541.0+50.8 570.5+71.5 29.4 0.059 -60.1 1.3 0.5 
6MWT 
(High) 
530.7+87.9 570.1+82.0* 39.4 0.002 -61.8 -16.9 0.9 
TUG (Low) 4.6+1.2 4.1+1.0 -0.5 0.135 -0.2 1.1 0.4 
TUG 
(High) 
5.0+1.3 4.4+1.6* -0.6 0.013 0.2 1.1 0.7 
Balance 
(Low) 
69.9+13.3 77.8+12.1* 7.9 0.009 -13.5 -2.3 0.8 
Balance 
(High) 
73.0+10.6 75.5+9.2 2.5 0.158 -6.2 1.1 0.4 
Fatigue 
(Low) 
16.6+3.7 16.4+3.0 -0.3 0.624 -0.9 1.5 0.1 
Fatigue 
(High) 
16.9+5.8 15.4+5.0 -1.6 0.104 -0.4 3.5 0.4 
Pain (Low) 11.4+6.7 10.5+3.8 -0.9 0.500 -1.8 3.5 0.2 
Pain (High) 11.8+7.0 10.6+5.0 -1.2 0.577 -3.2 5.6 0.1 
AppCog 
(Low) 
61.6+25.1 50.9+13.6* -10.7 0.028 1.3 20.1 0.7 
AppCog 
(High) 
68.3+33.9 66.4+29.5 -1.9 0.730 -9.5 13.2 0.1 
SEPA 
(Low) 






16.9+3.8 17.9+2.2 1.0 0.261 -2.6 0.6 0.3 
ISSI (Low) 9.5+5.2 7.1+4.6* -2.4 0.018 0.5 4.2 0.7 
ISSI (High) 8.3+5.6 7.3+4.7 -1.0 0.261 -0.8 2.8 0.3 
QoL (Low) 85.3+14.3 84.6+18.4 -0.7 0.887 -10.0 11.4 0.0 
QoL (High) 79.9+11.9 85.8+15.2** 5.9 0.050 -11.9 0.0 0.5 
* p < 0.05 from pre to post intervention 
** p = 0.05 from pre to post intervention  
(small effect size, d = .2 - .5: medium effect size, d = .5 - .8: large effect size, d  > .8) 
  
 Hypothesis 5, which stated that those subjects who reached the threshold of high 
adherence would present with greater magnitudes of change for all variables compared to those 
with low adherence was true for the following variables: %BF, LBM, 6MWT, TUG, fatigue, 
pain, SEPA, and QoL. Of these variables, statistical significance was observed for 6MWT with a 
large effect size of 0.9, and TUG with a medium effect size of 0.7. QoL for the high adherence 
group returned a p-value of 0.05, which had a corresponding medium effect size of 0.5. Figure 7 
and Figure 8 below show the differences between 6MWT and TUG group means for low and 












Figure 7: Adherence Comparison for Pre and Post Testing: 6MWT (meters) 
 
* p < 0.05 from pre to post intervention 
 
Figure 8: Adherence Comparison for Pre and Post Testing: TUG (seconds) 
 
* p < 0.05 from pre to post intervention 
 
 
 Of note, for the isokinetic leg extension, post intervention values decreased for both 
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terms of strength, and the same was true for isometric row, despite starting at similar baseline 
scores for each variable. For balance, though the low adherence group began with a lower mean 
baseline score, the group also saw a magnitude of change 3x that of the high adherence group, 
and the post intervention scores for low adherence were greater than the high adherence group. 
Applied cognition scores declined for both groups, but the change was greater in the low 
adherence group; this group also began with much lower baseline scores. ISSI scores, which 
measures sleep insomnia, was better in the low adherence group, though baseline scores for for 
this group were much greater. Finally, QoL scores declined from pre to post intervention for the 
low adherence group, while the high adherence group nearly presented statistically significant 
changes with a p-value equal to 0.05.  
 On an extra exploratory basis, a second adherence analysis was run using only the lowest 
and highest quartiles for attendance. For this analysis, the low adherence quartile (n = 8) 
represented attendance values of 62% or below, and the high adherence quartile (n = 9) 
represented attendance of 87.5% or above. From here, dependent t-tests were used for each 
adherence group. The results can be seen in Table 9 below. 
 
Table 9: Adherence Comparison of Lower and Upper Quartiles (mean + SD) 










37.9+7.3 37.9+7.6 0.0 0.935 -1.8 1.7 0.0 
%BF 
(High) 






43.2+6.2 43.0+7.3 -0.2 0.796 -1.4 1.8 0.1 
LBM 
(High) 
41.9+7.9 42.8+6.6 0.9 0.301 -2.9 1.0 0.4 
VO2 (Low) 21.9+6.7 23.4+7.2 1.5 0.518 -5.3 3.0 0.3 
VO2 (High) 18.8+3.5 20.8+4.6 2.0 0.054 -4.0 0.0 0.8 
ISOK LE 
(Low) 
92.6+15.1 86.7+13.4 -5.9 0.674 -12.6 18.1 0.2 
ISOK LE 
(High) 
78.6+18.4 73.1+31.0 -5.5 0.486 -11.8 22.8 0.2 
ISOM LE 
(Low) 
117.0+22.3 127+36.7 10.0 0.194 -33.5 8.4 0.6 
ISOM LE 
(High) 
94.0+18.6 101+27.7 7.0 0.249 -20.8 6.2 0.4 
ISOM Row 
(Low) 
70.7+28.1 76.8+18.7 6.1 0.531 -26.7 15.3 0.3 
ISOM Row 
(High) 
59.7+16.7 62.9+19.6 3.2 0.567 -15.5 9.1 0.2 
6MWT 
(Low) 
551.0+51.0 583.0+60.8 32.0 0.134 -77.0 12.7 0.6 
6MWT 
(High) 
509.0+102.0 547.0+90.4* 38.0 0.039 -73.8 -2.5 0.8 
TUG (Low) 4.3+0.9 4.0+1.1 -0.3 0.480 -0.7 1.4 0.3 
TUG 
(High) 
5.5+1.3 4.8+1.9 -0.7 0.131 -0.3 1.6 0.6 
Bal (Low) 71.9+14.1 80.4+9.9 8.5 0.119 -20.8 3.1 0.7 






16.8+3.5 16.3+3.1 -0.5 0.582 -1.5 2.5 0.2 
Fatigue 
(High) 
16.7+7.9 16.0+5.8 -0.7 0.422 -2.4 5.2 0.3 
Pain (Low) 11.3+6.9 9.6+2.0 -1.7 0.435 -3.0 6.3 0.3 
Pain (High) 13.2+8.9 10.0+3.6 -3.2 0.267 -3.7 11.5 0.4 
AppCog 
(Low) 
61.8+21.1 51.5+15.7* -10.3 0.046 .3 20.2 0.9 
AppCog 
(High) 
69.6+44.4 70.5+36.3 0.9 0.808 -13.6 16.8 0.1 
SEPA 
(Low) 
13.0+4.8 15.1+3.6 2.1 0.364 -7.3 3.1 0.3 
SEPA 
(High) 
15.3+3.7 17.9+2.4 2.6 0.059 -3.8 0.1 0.8 
ISSI (Low) 11.4+4.9 8.8+5.0 -2.7 0.090 -0.5 5.8 0.7 
ISSI (High) 6.7+5.8 4.6+3.2 -2.0 0.109 -0.7 5.7 0.6 
QoL (Low) 78.8+15.7 74.4+18.2 -4.4 0.621 -15.6 24.4 0.2 
QoL (High) 76.2+12.8 84.8+12.8* 8.6 0.005 -16.2 -4.1 1.4 
* p < 0.05 from pre to post intervention 
(small effect size, d = .2 - .5: medium effect size, d = .5 - .8: large effect size, d  > .8) 
 
 For this analysis, statistical significance was found for the high adherence quartile in 
6MWT with a large effect size of 0.8, and QoL which returned an effect size of 1.4. There was 
also a statistically significant decrease in applied cognition in the low adherence quartile, with a 
corresponding large effect size of 0.9. Greater magnitudes of change trending toward 
improvement in response to the intervention were seen in the following variables: %BF, LBM, 




cognition, SEPA (large effect size of 0.8), ISSI, and QoL. In addition to this, QoL in the low 
adherence quartile actually decreased, while QoL in the high adherence quartile improved 
significantly. 
 
Figure 9: Adherence Quartile Comparison for Pre and Post Testing: QoL  
 









































 The purpose of this study was to determine the effectiveness of a 16-week aerobic and 
strength exercise intervention on the fitness, physical function, and QoL in BCS. Exercise for 
people who have undergone treatment for breast cancer has shown to be a safe and effective 
means for alleviating treatment related side effects, but to date, studies evaluating the 
effectiveness of group-based exercise interventions that translate these findings to real-world 
applications are still lagging behind37. The aim of this study was to show that laboratory-based 
results could be translated to real-world settings, which could serve as a model for other cancer 
centers to serve more survivors at a low cost. As the pool of cancer survivors continues to grow 
with the advent of newer and more effective treatment protocols, the scalability of programs such 
as GRH becomes paramount, so that more survivors are able to be reached1. In the short term, 
exercise can aid survivors in living more comfortable lives, and in the long term, can potentially 
cut down on future health care costs, and perhaps even the recurrence of cancer38,39.  
Multiple studies have shown that physical activity is associated with an overall decrease 
in mortality in BCS, with one study showing that exercise can reduce the chance of death up to 
25%, and other studies showing a decrease in mortality ranging from 29%-34%40,41. In addition 
to this, a study of Norweigan BCS revealed that physical activity post-diagnosis reduced both 
breast cancer and all-cause mortality with a dose-response relationship, and also showed that 
BCS who either reduced their physical activity or maintained their inactive lifestyle post-
50 
 
diagnosis had an increase in all-cause and breast cancer mortality compared to those who 
maintained their physical activity levels42. An individually tailored exercise protocol is an 
important component of an effective prescription, especially in those who are previously 
sedentary, however, much work is still needed in determining the best way to get survivors to 
maintain these habits regularly for long term health and QoL10.  
 
Fitness and Physical Function 
 
 Significant changes were observed in VO2peak, isometric leg extension, 6MWT, TUG, and 
composite balance scores from pre to post intervention amongst all subjects. It is possible that 
these improvements can be attributed directly to the exercise intervention, however, future 
studies should consider certain measures to control for the learning effect from pre to post 
testing. 
 For this study, VO2peak values increased significantly following the exercise intervention, 
with a mean difference of 1.3 ml*kg-1*min-1, supporting the hypothesis. Studies have shown that 
VO2 values in BCS are typically lower than female controls, and VO2max values can help 
clinicians assess certain aspects of cardiovascular health such as overall cardiovascular function, 
oxygen transport and utilization, and cardiopulmonary reserve43. This same study also showed 
that the mean VO2max of 50 year old BCS most closely mimicked that of 60 year old, healthy yet 
sedentary women43. Being that VO2 values are a good predictor of both breast cancer specific 
mortality as well as all-cause mortality, any increase, be it statisitical or clinical, is beneficial in 
terms of cardioprotective measures. With fatigue and endurance being such a common complaint 
amongst BCS, the improvement in VO2 values can be seen as a positive step toward combating 




exercise intensity was evaluated more broadly on the Borg Rating of Perceived Exertion scale. 
The use of constant heart rate monitoring in the future could potentially elicit more dramatic 
VO2peak values during post-testing, as subjects would be more inclined to comply more closely 
with protocol guidelines. It is possible that aerobic intensities were lower than reported via the 
Borg RPE scale as subjects learned throughout the intervention where their RPE range should be 
and reported that number accordingly. 
  Looking at VO2 values under adherence conditions, when the group was split in to low 
and high attendance at the 75% attendance mark, the low adherence group actually improved to a 
greater magnitude (1.37 vs 1.16). However, when the middle 50% of attendees was removed 
from the analysis, and therefore only the lowest and highest quartile of attendees was were 
calculated, the high attendance group had a larger increase (2.0 vs 1.5), so the difference in 
improvement was greater amongst those who attended at least 50% more of the offered classes. 
With compliance aside, this could perhaps exemplify that merely attending more sessions and 
performing exercise in any capacity could help maintain or improve aerobic fitness compared to 
those who missed more sessions.  
 Muscle strength improved statistically in the isometric leg extension, and in the isometric 
row, although not significantly, supporting the hypothesis. Lower body strength increases tend to 
fall in line with many other studies26,44,45. The majority of studies assessing upper body strength 
tended to assess grip strength and bench press as opposed to the row, and although the current 
study did not find statistically significant improvement in the row, the findings could be deemed 
clinically significant. Following invasive surgery for breast cancer, damage to the tissues in the 
upper extremeties and shoulder girdle could hinder mobility and strength, and therefore any 




Finding that BCS can resistance train at a moderate level and make improvements all while 
staying safe could help remove the fear that can become a barrier to exercise post-treatment. 
Compliance values for strength training in the current study were much lower than expected, and 
future increases in strength intensity across the 16-week intervention could elicit greater changes 
in magnitude of strength. Interestingly, under both conditions of adherence analysis provided in 
the results section, the low adherence group had greater improvements in strength when 
compared to the high adherence group in both the isometric leg extension and the isometric row. 
Isokinetic leg extension values declined in both groups in both analyses. The cause of these 
results is unclear, but perhaps those with lower attendance numbers actually benefited from the 
rest and experienced less fatigue. It is important for trainers to note that while strength 
improvements are important, it is vital to have the survivor working in a comfortable and safe 
range of motion, keeping in mind that more intense loading might have to wait until proper and 
range of motion can be restored; an issue that is especially seen in BCS who underwent radiation 
and/or mastectomy surgery. 
6MWT improvements are in line with a 2017 meta-analysis studying the effect of home 
and community-based exercise intervention on cancer survivors, which showed that the largest 
effect sizes for 6MWT were seen in the community-based interventions that met in groups11. In 
addition to this, 12-Minute walk distances, another measure of physical function, were 
significantly improved in exercise groups compared to controls in women who were being 
treated for early stage breast cancer46. The GRH group realized an increase in mean walk 
distance of 34m from pre to post intervention, supporting the hypothesis. Another test of physical 
function, the TUG, showed significant improvement, with mean time values differing by -0.57s, 




is important, as a 2007 study of BCS treated with taxane chemotherapy showed to have 
statistically significant detriments in TUG scores compared to healthy controls47. Another study 
analyzed the correlative effect of peripheral neuropathy scores on balance and TUG testing, and 
revealed that there was a positive correlation between neuropathy and TUG, meaning that those 
who had more pronounced peripheral neuropathies tended to take longer on the TUG48. These 
two tests of physical function display an increase in endurance and dynamic balance, both of 
which could potentially correlate to an increase in the ability to perform activities of daily living, 
as well as promote independent living.  
Values for the 6MWT showed a greater magnitude of change for the high adherence 
group compare to the low adherence group under both analytic conditions. Interestingly, the 
magnitude of change was greater under the 75% attendance split compared to the quartile split 
(9.96 vs 6.0). When analyzing TUG scores, the high adherence group saw a greater change under 
both adherence conditions. With a 75% attendance split, the high attendance group did .17s 
better than low adherence, and with a quartile split, the high adherence group performed .34s 
better than the lower attendees. Physical function improvements are vital to self-efficacy and 
independence as BCS age, and the exercise intervention for this study has shown to make 
significant improvements in those values which will hopefully mitigate any long-term 
deleterious effects of cancer treatment.  
In the current study, composite balance scores from the SOT improved significantly. The 
SOT, which measures the ability of the body’s visual, somatosensory, and vestibular feedback 
systems to correct for postural changes and sway, reveals a score from 0 to 100, with lower 
scores indicating more sway, and a score of zero representing a fall. The use of the Neurocom 




such as one leg static stance and backward tandem walk. However, one study utlizing the 
Neurocom SOT found that BCS performed poorly compared to healthy controls on all conditions 
of the SOT except for Condition 1, in which the subject stands with eyes open on a stable 
surface, with no movement of their surroundings47. However, this trial did not include an 
exercise intervention to test for improvements, and instead analyzed baseline balance values as 
compared to healthy controls. A second study revealed that balance as measured via the 
Neurocom SOT was significantly inversely correlated with modified Total Neuropathy Scores48. 
This study also did not include an exercise intervention, however the results from the current 
study are promising, as it can now be seen that exercise may have an affect on overall balance 
scores.  
When looking at composite balance scores from an adherence perspective, the low 
adherence group had a greater magnitude of improvement under both adherence conditions, and 
although beginning with a lower group mean than the high adherence group, the low adherence 
group finished with a higher group mean that high adherence. This finding is of particular 
interest as balance exercises were a part of the strength training protocol for this intervention, 
and the assumption of more balance practice being equal to better balance was not upheld.  
Though not significant, both %BF and LBM trended toward improvement from pre to 
post intervention. When analyzed under adherence conditions, high adherence favored greater 
loss of %BF, and greater improvements in LBM. With a 75% attendance split, the low adherence 
group actually had an overall increase in %BF and decrease in LBM, while high adherence 
experienced a decrease in %BF and an increase in LBM, favoring high adherence. The same was 




change in %BF. Overall this would tend to display that attending more exercise sessions had a 
positive effect on both %BF and LBM. 
Patient Reported Outcomes and Quality of Life 
 
 In the current study, only improvements in sleep insomnia were statistically significant. 
However, there were clinical improvements in fatigue, pain interference, self-efficacy for 
physical activity, and overall QoL. A decline was seen in applied cognition following the 
intervention. With QoL of BCS being of the utmost importance, these results are promising for 
survivors and trainers, alike. Improvements in sleep could likely improve fatigue, and decreases 
in pain along with increases in self-efficacy for physical activity could bolster a survivor’s desire 
for exercise. Results on PROs and QoL in BCS following an exercise intervention are mixed, 
with minimal studies showing statistical significance, thought most do elicit trends toward 
improvements in response to exercise8.  
 When evaluating the response to exercise for PROs from an adherence perspective, 
results favored the high adherence group under both conditions for all measures with the 
exception of sleep insomnia. In the quartile split, applied cognition actually decreased for the low 
adherence group by a magnitude of 10.0, while the high adherence group had a slight increase in 
cognition. The same trend was seen in overall QoL. Under both adherence conditions, the low 
adherence group actually saw a decline in QoL values, while the high adherence group saw a 
dramatic increase. Specifically for the quartile split, the low adherence group saw a decline by a 
magnitude of 4.4, while the high adherence group improved by a magnitude of 8.6. It could be 
speculated that the act of showing up for exercise, with improvements in physical function and 







 From a clinical perspective, the importance of a trainer knowing the abilties and 
limitations of their clients in this population cannot be understated. Guidelines should be 
followed, but it is also the responsibility of the trainer to know based on feel when a BCS needs 
to deviate from protocol. Approaching the training session with a plan is necessary, but knowing 
when the plan must be changed is even more important. On a day-to-day basis, the life of a BCS 
is unpredictable in terms of management of side-effects. Knowing when to alter the exercise 
prescription or cancel the session can sometimes be more useful than compliance values in terms 
of the health and well-being of subjects. This is even more prescient in a group-based exercise 
format, where a trainer might be forced to attend to 5, sometimes 10 people at once. For this 
reason, it is imperative to clarify to participants that although the exercise is done in a group 
format, all exercises are still to be individually administered based on ability and fitness level. 
When working with a clinical population, it is important to remember that in many cases even 
maintenance without decline can be clinically relevant for many variables. For this reason, when 
training BCS in small groups, attention must be given to safe and effective long-term 
improvements, perhaps at the expense of immediate results.  
 Trainers must also be cognizant of some barriers that BCS face. Proper shoulder mobility 
following invasive surgeries (mastectomy, lymph node dissection, etc.) can be difficult for many 
survivors. Range of motion is important, but proper movement through that range of motion 
needs to be addressed to mitigate future complications at the joint, as treatments for breast cancer 
can affect more than just the gleno-humeral joint itself49. Trainers must be aware of potential 
damage to muscle and other soft tissue, and be aware not to rush strength improvements if proper 




Future Research and Limitations 
 
 More research is needed on the efficacy of community-based, non-laboratory group 
exercise for the alleviation of treatment-related side effects. Future studies investigating different 
exercise intensities could help gain a better perspective of what the best protocol is in a group-
based setting. The addition of a non-exercise group that undergoes pre and post testing without 
the 16-week intervention could also determine what progress that is made over the course of the 
16 weeks was due primarily to exercise, and how much of it could be attributed to the subject 
being 16 weeks further removed from treatment. This study might have also benefited from 
VO2peak testing being done on a treadmill rather than a cycle ergometer, as this was the most 
popular form of aerobic exercise for subjects. Finally, being that the results of this study hope to 
inform exercise trainers on how a protocol can influence fitness and physical function in BCS, 
strength testing that is more functional and mimics everyday movements would perhaps help to 
shed light on any limitations due to range of movement. While the isometric row is able to 
determine empirical strength values, it does not take into account the potential lack of range of 
motion that is associated with more invasive forms of breast cancer surgery. It might correct for 
it, but from the perspective of a trainer it does not inform about strength through the entire range 
of motion. Likewise, a leg press test in place of isometric and isokinetic leg extension can 




 This study provided results that tended to favor the inclusion of exercise into normal 
lifestyle habits of survivors following treatment for breast cancer. Though only some of the 
results of this study were statistically significant, all results trended toward exercise being a 




clinical population, any improvement or maintenance of physiological and psychological 
variables is important in maintaining quality of life and independence with aging. From the 
perspective of an exercise trainer, knowing that an exercise protocol has been successful in 
eliciting meaninful changes in survivors is helpful when determining a protocol for an indivual 
subject. The knowledge of having a moderate intensity exercise regimen such as the GRH trial 
bring about positive changes in survivors can help identify other areas of improvement across 
individuals and groups, when these exercises are administered in similar or greater intensities, 
depending on the person’s needs.  
 Moving forward, the onus lies on both each individual survivor and the trainer they work 
with to design an effective workout strategy. It is up to the survivor to communicate to the trainer 
how they are feeling each day during each exercise, and it is the responsibility of the trainer to 
design a program that best fits that survivor’s needs and abilities. As the popularity of exercise 
programs for BCS continues to grow and show promise, the demand for knowledgeable, capable, 
and competent trainers will grow with it. Group exercise may be the way forward, but the 










APPENDIX 1: DATA COLLECTION SHEET 
 
DAY 1 PRE-TESTING 
 
Subject ID: _______________________ Date: _____________ Cohort: _________ 
 
Immune Subset:  Y N     Questionnaires complete and collected?     Y          N 
 




Height (cm): __________________  Weight (kg):                
 
DOB: ______/_______/__________  Age:_____________ 
 
 
DEXA   Printout: Y N 
 
 
Ultrasound Assessment  
 
Half Femur Length (cm):     
 




Arm Side:  R  L 
 
Carotid to Notch: __________cm  Notch to Top of Cuff: __________cm 
 
Femoral to Cuff: __________cm   
 





 Systolic Blood Pressure     mmHg 
 Diastolic Blood Pressure     mmHg 
 Heart Rate     bpm 
 Central Systolic Blood Pressure     mmHg 
 Mean Arterial Pressure     mmHg 
 Augmentation Index     % 
 AIx @ 75      
 Pressure forward     mmHg 




 Reflection magnitude     % 
 Buckburg Index (SEVR)      







Electrocardiogram (ECG)  
 





Stroke Vol: ___________  Cardiac Output:    
 





6-minute Walk Test:    #laps x    45.72   =    meters 
 
TUG:    s   s best =    s 
 
 
Familiarization for Cardiopulmonary Assessment (VO2peak) 
 
Mask Size:       Seat Height (in):     
 
Heart Rate (75%):________________  [Use: ((220-age)-RHR)*.75)+RHR]  *(RHR from ECG) 
 
**Begin at 20Watts: 





 Systolic Blood Pressure     mmHg 
 Diastolic Blood Pressure     mmHg 
 Heart Rate     bpm 
 Central Systolic Blood Pressure     mmHg 
 Mean Arterial Pressure     mmHg 
 Augmentation Index     % 




 Pressure forward     mmHg 
 Pressure backwards     mmHg 
 Reflection magnitude     % 
 Buckburg Index (SEVR)      
 
    







DAY 2 PRE-TESTING 
 
Subject ID: _______________________  Weight (kg):           
 
 










Cardiopulmonary Assessment (VO2peak) 
  






VO2peak Total Exercise Time  Mm:ss 
 RPE final stage   
 Heart Rate max  bpm 
 
VO2 peak (average of 3 highest 
VO2 in last stage)  mL/kg/min 
 Ventilatory Threshold  
% of mL/kg/min 
(peak) 
 Lactate  mmol 
3 minutes post max: 





 Systolic Blood Pressure     mmHg 
 Diastolic Blood Pressure     mmHg 
 Heart Rate     bpm 
 Central Systolic Blood Pressure     mmHg 
 Mean Arterial Pressure     mmHg 
 Augmentation Index     % 
 AIx @ 75      
Stage Total Time Work Load 
HR  
(bpm) RPE 
Rest (seated) ~0-2:59 Not cycling Collect 1 & 2 below at ~2:45 
ENTER PORTASYNC MARKER AT END OF 3min REST STAGE 




Up 3-4:59 0W   
Loaded Warm 
Up 5-7:59 20W   
1 10:00 50W   
2 12:00 80W   
3 14:00 110W   
4 16:00 140W   
5 18:00 170W   
6 20:00 210W   
AT 
TERMINATION     




 Pressure forward     mmHg 
 Pressure backwards     mmHg 
 Reflection magnitude     % 
 Buckburg Index (SEVR)      




HUMAC Trial # BioPAC File Name Units 
Gravity Corrected Leg Weight T1   
isokinetic Leg ext (60/sec) T1  Nm/s 
 T2  Nm/s 
 T3  Nm/s 
Maximum Isometric Leg Ext T1  Nm 
 T2  Nm 
 T3  Nm 
Maximum Isometric Row T1  Nm 
 T2  Nm 




T1  kg 
T2  kg 
T3  kg 
 
Dominant Hand:  R    L 
 





DAY 3 : ACUTE EXERCISE (AE) PRE-TESTING 
 
 
Subject ID:________________ Date: _____________ Cohort: ___________ 
 
Surgery Side: R L n/a  Lymphedema:  R L n/a 
 
Vitals 





Seat Height (in):    
 
60% max Wattage: _________________ W (Max test Wattage: _______________ W) 
 
Max HR from VO2max: _________________bpm 
 




RPE Blood Sample 
Warm Up ~1:00 0W    
Warm Up 1:00 50% W    
1-1 3 min     
1-2 1.5 min 0W    
2-1 3 min     
2-2 1.5 min 0W    
3-1 3 min     
3-2 1.5 min 0W    
4-1 3 min     
4-2 1.5 min 0W    
5-1 3 min     
5-2 1.5 min 0W    
6-1 3 min     
6-2 1.5 min 0W    
7-1 3 min     
7-2 1.5 min 0W    
8-1 3 min     
8-2 1.5 min 0W    
9-1 3 min     
9-2 1.5 min 0W    
10-1 3 min     
10-2 1.5 min 0W    
 




APPENDIX 2: FACT-G 
 
 
Below is a list of statements that other people with your illness have said are important. 
Please circle or mark one number per line to indicate your response as it applies to 
the past 7 days. 
 
 














I have a lack of energy
 .............................................................. 





0 1 2 3 4 
G
P3 
Because of my physical condition, I have 
















0 1 2 3 4 
G
P5 
I am bothered by side effects of 
treatment
 .............................................................. 





0 1 2 3 4 
G
P7 
I am forced to spend time in bed
 .............................................................. 
0 1 2 3 4 
 














I feel close to my friends
 .............................................................. 
0 1 2 3 4 
G
S2 
I get emotional support from my family
 .............................................................. 
0 1 2 3 4 
G
S3 
I get support from my friends
 .............................................................. 
0 1 2 3 4 
G
S4 
My family has accepted my illness
 .............................................................. 







I am satisfied with family 














I feel close to my partner (or the person 












Q1 Regardless of your current level of 
sexual activity, please answer the 
following question. If you prefer not to 
answer it, please mark this box           
and go to the next section. 
     
G
S7 
I am satisfied with my sex life
 .............................................................. 





Please circle or mark one number per line to indicate your response as it applies to the past 7 days. 
 
 












 .............................................................  
0 1 2 3 4 
G
E2 
I am satisfied with how I am coping with 
my illness
 .............................................................  
0 1 2 3 4 
G
E3 
I am losing hope in the fight against my 
illness
 .............................................................  




 .............................................................  
0 1 2 3 4 
G
E5 
I worry about dying
 .............................................................  
0 1 2 3 4 
G
E6 
I worry that my condition will get worse
 .............................................................  




 FUNCTIONAL WELL-BEING 
 












I am able to work (include work at 
home)
 ..........................................................  
0 1 2 3 4 
G
F2 
My work (include work at home) is 
fulfilling
 ..........................................................  
0 1 2 3 4 
G
F3 
I am able to enjoy life
 ..........................................................  
0 1 2 3 4 
G
F4 
I have accepted my illness
 ..........................................................  
0 1 2 3 4 
G
F5 
I am sleeping well
 ..........................................................  






I am enjoying the things I usually do 
for fun
 ..........................................................  
0 1 2 3 4 
G
F7 
I am content with the quality of my life 
right now
 ............................................................ 
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